Current research status of transarterial therapies for hepatocellular carcinoma

doi:10.4251/wjgo.v16.i9.3752

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (89)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=41

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=44

Publishing Process of This Article

Item

Count

Browse

Download

Sum=1

Sep 15, 2024 (publication date) through Sep 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3752-3760
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3752

Current research status of transarterial therapies for hepatocellular carcinoma

Mao-Ting Zhou, Peng Zhang, Qi Mao, Xiao-Qin Wei, Lin Yang, Xiao-Ming Zhang

Mao-Ting Zhou, Peng Zhang, Qi Mao, Lin Yang, Xiao-Ming Zhang, Department of Radiology, Interventional Medical Center, Science and Technology Innovation Center, The Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China

Xiao-Qin Wei, School of Medical Imaging, North Sichuan Medical College, Nanchong 637000, Sichuan Province, China

Co-first authors: Mao-Ting Zhou and Peng Zhang.

Author contributions: Zhou MT and Zhang P contributed equally; Zhou MT, Zhang P, Mao Q, Wei XQ, Yang L and Zhang XM contributed to this paper; Yang L and Zhang XM designed the manuscript; and Zhou MT, Zhang P, Mao Q, Wei XQ and Yang L contributed to the writing and editing of the manuscript.

Supported by the Project of City-University Science and Technology Strategic Cooperation of Nanchong City, No. 20SXQT0324.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Lin Yang, MD, Professor, Department of Radiology, Interventional Medical Center, Science and Technology Innovation Center, The Affiliated Hospital of North Sichuan Medical College, No.1 South Maoyuan Road, Nanchong 637000, Sichuan Province, China. linyangmd@163.com

Received: March 11, 2024
Revised: May 22, 2024
Accepted: May 30, 2024
Published online: September 15, 2024
Processing time: 182 Days and 1.1 Hours

Core Tip

Core Tip: Articles on transarterial therapies for hepatocellular carcinoma (HCC) were systematically reviewed. The results of this study showed that transarterial therapies combined with systemic therapy strategies are research hotspots in this field, and researchers dedicated to transarterial therapies for HCC should pay attention to these topics in the future.